The use of maternal plasma for prenatal RhD blood group genotyping

Methods in Molecular Biology

Volumn 496, Issue , 2009, Pages 143-157

  Finning, Kirstin ^a   Martin, Pete ^a   Daniels, Geoff ^a  

^a NHS BLOOD AND TRANSPLANT   (United Kingdom)

Author keywords

Blood groups; D; Fetal testing; Free fetal DNA; Hemolytic disease of the fetus and newborn; Rh

Indexed keywords

ALLOANTIBODY; DNA; RHO(D) ANTIBODY; RHO(D) ANTIGEN; UNCLASSIFIED DRUG;

BLOOD; BLOOD GROUP RHESUS SYSTEM; EXON; FEMALE; GENETICS; HUMAN; IMMUNOLOGY; MALE; METHODOLOGY; NEWBORN HEMOLYTIC DISEASE; PLASMA; POLYMERASE CHAIN REACTION; PREGNANCY; PRENATAL DIAGNOSIS; REVIEW; UNITED KINGDOM;

DNA; ENGLAND; ERYTHROBLASTOSIS, FETAL; EXONS; FEMALE; HUMANS; ISOANTIBODIES; MALE; PLASMA; POLYMERASE CHAIN REACTION; PREGNANCY; PRENATAL DIAGNOSIS; RH-HR BLOOD-GROUP SYSTEM;

EID: 58149316091     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-59745-553-4_11     Document Type: Article

References (14)

1. Klein, H. G., Anstee, D. J. (2005) Blood Transfusion in Clinical Medicine, 11th edition. Blackwell Publishing, Oxford, UK.
2. National Institute for Clinical Excellence (2002) Technology Appraisal Guidance 41. Guidance on the Use of Routine Antenatal Anti-D Prophylaxis for RhD-Negative Women. NICE, London, UK.
3. van der Schoot, C. E., Tax, G. H. M., Rijnders, R. J. P., de Haas, M., Christiaens, G. C. M. L. (2003) Prenatal typing of Rh and Kell blood group system antigens: the edge of a watershed. Transfus Med Rev 17, 31-44.
4. Daniels, G., Finning, K., Martin, P., Soothill, P. (2004) Fetal blood group genotyping from DNA from maternal plasma: an important advance in the management and prevention of haemolytic disease of the fetus and newborn. Vox Sang 87, 225-232.
5. Daniels, G., Finning, K., Martin, P., Summers, J. (2006) Fetal blood group genotyping. Present and future. Ann NY Acad Sci 1075, 88-95.
6. Lo, Y. M., Tein, M. S. C., Lau, T. K., Haines, C. J., Leung, T. N., Poon, P. M. K., et al. (1998) Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. Am J Hum Genet 62, 768-775.
7. Finning, K. M., Martin, P. G., Soothill, P. W., Avent, N. D. (2002) Prediction of fetal D status from maternal plasma: introduction of a new noninvasive fetal RHD genotyping service. Transfusion 42, 1079-1085.
8. Finning, K., Martin, P., Summers, J., Daniels, G. (2007) Fetal genotyping for the K (Kell) and Rh C, c, and E blood groups on cell-free fetal DNA from maternal plasma. Transfusion 47, 2126-2133.
9. Daniels, G. (2002) Human Blood Groups, 2nd edition. Oxford: Blackwell Science.
10. Colin, Y., Chérif-Zahar, B., Le Van Kim, C., Raynal, V., Van Huffel, V., Cartron, J-P. (1991) Genetic basis of the RhD-positive and RhD-negative blood group polymorphism as determined by Southern analysis. Blood 78, 2747-2752.
11. Singleton, B. K., Green, C. A., Avent, N. D., Martin, P. G., Smart, E., Daka, A., et al. (2000) The presence of an RHD pseudogene containing a 37 base pair duplication and a nonsense mutation in most Africans with the Rh D-negative blood group phenotype. Blood 95, 12-18.
12. Faas, B. H. W., Beckers, E. A. M., Wildoer, P., Ligthart, P. C., Overbeeke, M. A., Zondervan, H. A., et al. (1997) Molecular background of VS and weak C expression in blacks. Transfusion 37, 38-44.
13. Page-Christiaens, G. C., Bossers, B., van der Schoot, C. E., De Haas, M. (2006) Use of biallelic insertion/deletion polymorphisms as a positive control for fetal genotyping in maternal blood: first clinical experience. Ann NY Acad Sci 1075, 123-129.
14. Chan, K. C., Ding, C., Gerovassili, A., Yeung, S. W., Chiu, R. W., Leung, T. N., et al. (2006) Hypermethylated RASSF1A in maternal plasma: A universal fetal DNA marker that improves the reliability of noninvasive prenatal diagnosis. Clin Chem 52, 2211-2218.